GSK shares dive as weaker vaccine sales and restructuring charges unnerve investors
British pharma company reports declining profits amid concerns over looming patent loss for blockbuster HIV drug
Business live – latest updates
Shares in GSK slid on Wednesday despite the UK drugmaker reporting better than expected financial results, as investors were unnerved by weaker vaccine sales, restructuring charges and its overall outlook.
Britain’s second-biggest pharmaceutical company reported a 19% decline in pre-tax profit to £1.9bn in the July to September quarter and £318m of restructuring charges, with more to come.
Continue reading...
评论
克里斯汀
九游体育以九游体育入口为核心，带来高效便捷的体验。
想了解更多九游体育下载相关内容，尽在九游体育。
克里斯汀
九游体育围绕九游体育不断创新，回应用户的真实需求。